Congress 118 - HR 1076 - Preventing the Financing of Illegal Synthetic Drugs Act

Sponsor

Cosponsors

Topics

Congressional oversight Drug trafficking and controlled substances Fraud offenses and financial crimes Government Operations and Politics Government studies and investigations Internet, web applications, social media Smuggling and trafficking

Full Text

View Full Bill Text

Votes

Summary

Preventing the Financing of Illegal Synthetic Drugs Act

This bill requires the Government Accountability Office to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.

Actions

Sep 13, 2024

Became Public Law No: 118-79.
Sep 13, 2024

Signed by President.
Sep 11, 2024

Presented to President.
Jul 24, 2024

Message on Senate action sent to the House.
Jul 23, 2024

Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Jul 23, 2024

Senate Committee on Banking, Housing, and Urban Affairs discharged by Unanimous Consent.
Jul 23, 2024

Passed Senate without amendment by Unanimous Consent. (consideration: CR S5319; text: CR S5319)
May 30, 2023

Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
May 22, 2023

Motion to reconsider laid on the table Agreed to without objection.
May 22, 2023

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 2 (Roll no. 228). (text: CR H2469)
May 22, 2023

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 2 (Roll no. 228). (text: CR H2469)
May 22, 2023

Considered as unfinished business. (consideration: CR H2483)
May 22, 2023

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
May 22, 2023

DEBATE - The House proceeded with forty minutes of debate on H.R. 1076.
May 22, 2023

Considered under suspension of the rules. (consideration: CR H2469-2471)
May 22, 2023

Mr. Luetkemeyer moved to suspend the rules and pass the bill, as amended.
May 22, 2023

Placed on the Union Calendar, Calendar No. 55.
May 22, 2023

Committee on Energy and Commerce discharged.
May 22, 2023

Committee on the Judiciary discharged.
May 22, 2023

Reported (Amended) by the Committee on Financial Services. H. Rept. 118-75, Part I.
Feb 28, 2023

Ordered to be Reported in the Nature of a Substitute (Amended) by Voice Vote.
Feb 28, 2023

Committee Consideration and Mark-up Session Held.
Feb 24, 2023

Referred to the Subcommittee on Health.
Feb 17, 2023

Referred to the Committee on Financial Services, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 17, 2023

Introduced in House

Amendments

Related Bills